BoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight Months

The fastest-growing national pharmaceutical technology platform simplifies prescription sourcing and fulfillment for over 1,750 clinics nationwide.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

BoomRx, a national pharmaceutical technology platform, has announced that it has surpassed $15.5 million in net order revenue and processed over 77,000 orders since launching in July 2025. The platform is now utilized by more than 1,750 clinics nationwide, averaging over 8,000 orders per month with an 85% client retention rate.

Why it matters

BoomRx's rapid growth highlights the increasing demand for centralized prescription management solutions that can streamline sourcing, reduce administrative burden, and support the development of specialized medical programs for clinics. As regulatory complexity and supply chain expectations evolve, BoomRx provides a single point of coordination to help practices scale efficiently while improving operational performance and patient satisfaction.

The details

The BoomRx platform connects a clinic's EMR directly to its proprietary pharmacy network, allowing physicians to send prescription orders automatically, track status in real-time, and maintain updated patient information without additional manual steps. The platform's API integration and flat-rate shipping have helped drive its adoption, with clinics embedding BoomRx into their workflows to reduce friction and focus on patient care rather than procurement.

  • BoomRx launched in July 2025.
  • The company has surpassed $15.5 million in net order revenue since launching.
  • BoomRx is now averaging over 8,000 orders per month across its growing network of over 1,750 clinics nationwide.

The players

BoomRx

A national pharmaceutical technology platform that unifies access to regulated 503A and FDA-registered 503B outsourcing facility products as well as other manufactured and brand medications through a single, secure ordering portal.

Kurt Lunkwitz

The founder and president of BoomRx.

Got photos? Submit your photos here. ›

What they’re saying

“Centralizing prescription sourcing and fulfillment is not optional for practices that want to expand personalized medicine programs responsibly.”

— Kurt Lunkwitz, Founder and President of BoomRx (PRNewswire)

“As regulatory complexity and supply-chain expectations evolve, physician practices are looking for operational clarity when it comes to prescription management. BoomRx provides a single point of coordination that supports growth without increasing administrative overhead.”

— Kurt Lunkwitz, Founder and President of BoomRx (PRNewswire)

What’s next

BoomRx will be showcasing its technology at the upcoming A4M Longevity Springfest 2026, April 11-12, in West Palm Beach, Fla., at Booth 1135.

The takeaway

BoomRx's rapid growth and high client retention rates demonstrate the increasing demand for centralized prescription management solutions that can streamline sourcing, reduce administrative burden, and support the development of specialized medical programs for clinics. As the regulatory landscape and supply chain expectations evolve, BoomRx provides a comprehensive platform to help practices scale efficiently while improving operational performance and patient satisfaction.